Back

Ablation therapy for atrial fibrillation in patients with attr-amyloidosis or diastolic dysfunction: evaluation of 12-month success rates

30 March 2025 (08:00 - 18:00)
Organised by: Logo
Congress Presentation Part of: Poster session 1: atrial tachyarrhythmias Rhythm Control, Catheter Ablation EHRA Premium Access EHRA 2025 European Heart Rhythm Association (EHRA)

About the speaker

Photo
Doctor Simon Michael Milz

German Heart Center of Munich, Munich (Germany)

156 More presentations in this session

Presentation thumbnail
Native left atrial tachycardias clinical and electrophysiological characteristics: insights from a national survey.
Doctor S. Bun (Nice, FR)
Abstract
Presentation thumbnail
A novel immersive catheter ablation simulator based on individualized 3D MR patients' heart models improves ablation performance of future electrophysiologists.
Ms N. Bacha (Lausanne, CH)
Abstract Slides
Presentation thumbnail
Safety and feasibility of same day discharge catheter ablation: initial German experience
Doctor S. Popescu (Luebeck, DE)
Abstract
Presentation thumbnail
Safety, obstetric and neonatal data trend of novel arrhythmia management in pregnant: zero-fluoroscopy catheter ablation vs. antiarrhythmic drugs
Doctor Z. Suleymen (Astana, KZ)
Abstract Slides Video
Presentation thumbnail
Sensor-enabled 3D electroanatomical model optimization in in-vivo porcine and benchtop models
Mr G. Wenzel (Minneapolis, US)
Abstract Slides

Access the full session

Session thumbnail
Poster session 1: atrial tachyarrhythmias

The Event

Event poster

EHRA 2025

30 March 2025 08:00 CET
You may be interested in
thumbnail
Congress Presentation
Catheter ablation for atrial fibrillation in patients with cardiac amyloidosis - Clinical characteristics and outcomes
thumbnail
Congress Presentation
Reduced heart failure hospitalizations and improved quality of life in cardiac amyloidosis patients undergoing atrial fibrillation ablation
thumbnail
Congress Presentation
Safety and efficacy of catheter ablation in patients with atrial arrhythmias and cardiac amyloidosis: a systematic review and meta-analysis

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources